Last $2.66 USD
Change Today 0.00 / 0.00%
Volume 142.4K
UNIS On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Stuttgart
As of 3:30 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

unilife corp (UNIS) Snapshot

Open
$2.67
Previous Close
$2.66
Day High
$2.73
Day Low
$2.64
52 Week High
03/19/14 - $5.80
52 Week Low
11/6/13 - $2.55
Market Cap
275.5M
Average Volume 10 Days
422.6K
EPS TTM
$-0.69
Shares Outstanding
103.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for UNILIFE CORP (UNIS)

Related News

No related news articles were found.

unilife corp (UNIS) Related Businessweek News

View More BusinessWeek News

unilife corp (UNIS) Details

Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs; Unifill Select for use of liquid stable drug or vaccine, or a diluent to reconstitute and deliver a lyophilized drug supplied in a vial; and Unifill Assure, a finger flange and a thumb press for the intuitive self-injection of biologics. It also provides Rita disposable auto-injector that is designed to inject the prefilled dose from a single Unifill syringe; and Lisa reusable auto-injector, which automates the removal of the needle shield and enhances needle insertion and retraction, as well as EZMix dual or multi-chamber prefilled syringe for the reconstitution and delivery of injectable therapies. In addition, the company offers the Ocu-ject, a device for the delivery of microliter sized doses of drugs; and Depot-ject, a device that is designed to enable the precise placement of a drug depot into the vitreous of the eye, as well as Micro-ject, a device for optimizing the delivery of drugs with microliter doses that are unsuited to conventional device technologies. Its customers include pharmaceutical and biotechnology companies. The company is headquartered in York, Pennsylvania.

159 Employees
Last Reported Date: 09/13/13

unilife corp (UNIS) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $630.0K
President and Chief Operating Officer
Total Annual Compensation: $511.5K
Vice President of Legal Affairs
Total Annual Compensation: $321.6K
Vice President of Corporate Quality & Regulat...
Total Annual Compensation: $266.8K
Compensation as of Fiscal Year 2013.

unilife corp (UNIS) Key Developments

Unilife Mulls Acquisitions

Unilife Corporation (ASX:UNS) filed a shelf registration. Unilife anticipate that the net proceeds from our sale of any securities will be used for general corporate purposes, including working capital, acquisitions, retirement of debt and other business opportunities.

Unilife Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014; Provides Revenue Guidance for the Fiscal Year 2014 and 2015

Unilife Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company reported revenue of $1.38 million compared to $0.69 million a year ago. Operating loss was $14.31 million compared to $13.50 million a year ago. Net loss was $15.11 million compared to $14.08 million a year ago. Net loss per basic and diluted common share was $0.15 compared to $0.17 a year ago. Adjusted net loss was $11.67 million compared to $9.40 million a year ago. Adjusted net loss per basic and diluted common share was $0.12 compared to $0.12 a year ago. This increase in adjusted net loss is primarily attributable to increased investment in R&D. Adjusted net loss excludes non-cash share-based compensation expense, depreciation and amortization and interest expense. For the nine months, the company reported revenue of $8.14 million compared to $2.08 million a year ago. Operating loss was $37.02 million compared to $39.42 million a year ago. Net loss was $42.64 million compared to $41.22 million a year ago. Net loss per basic and diluted common share was $0.44 compared to $0.52 a year ago. Adjusted net loss was $27.05 million compared to $28.17 million a year ago. Adjusted net loss per basic and diluted common share was $0.28 compared to $0.36 a year ago. Net cash used in operating activities was $12.982 million against $30.91 million a year ago. Purchases of property, plant and equipment were $3.4 million against $1.931 million a year ago. The company provided revenue guidance for the fiscal year 2014 and 2015. The company expects fiscal year 2014 recognized revenue to be in the range of $12 million to $15 million. The company expects that revenue for financial year 2015 will be significantly higher than 2014 fiscal year.

Unilife Corporation Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 11:30 AM

Unilife Corporation Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 11:30 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Alan D. Shortall, Chairman, Chief Executive Officer, Member of Strategic Partnerships Committee and Chief Executive Officer of UMSL, Stephen Allan, Vice President of Marketing and Communications.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UNIS:US $2.66 USD 0.00

UNIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for UNIS.
View Industry Companies
 

Industry Analysis

UNIS

Industry Average

Valuation UNIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNILIFE CORP, please visit www.unilife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.